PALTC23 Conference Recordings SA20 Improving Opioid and Substance Use Disorder Care Quality Among Nursing Home Residents

Improving Opioid and Substance Use Disorder Care Quality Among Nursing Home Residents

During this panel, we will explore disparities, quality measurement, ethical issues, and educational interventions to improve care for persons with OUD/SUD who receive care in NHs. Specifically, this session will assemble evidence on the following topics: an overview of disparity in OUD/SUD care delivery; ethical issues related to patient acceptance and treatment; methodological issues related to quality measurement; and implementation of curricula for enhanced care competency. Throughout the session, we will generate case-based discussions that illustrate common issues experienced by administrators and staff when transitioning to and providing care within post-acute and long-term care settings. Attendees will learn the principles and techniques to provide high-quality OUD/SUD care.

Learning Objectives:

At the completion of this session, learners will be able to:

  • Define the key areas of disparity in opioid and substance use disorder (OUD/SUD) care delivery.
  • Explain the core ethical principles related to the care delivery for older adults with OUD/SUD.
  • Understand the core elements of Delphi method and steps to develop consensus-based measures of the quality of OUD/SUD care in NHs.
  • Examine lessons learned about interprofessional collaborative practice from implementation of curriculum on OUD/SUD in LTC.

Rossana Lau-Ng, MD, MBA, CMD

Rossana Lau-Ng, MD, MBA, CMD, is a geriatrician and clinician educator who practices in post-acute and long-term care. She has a scholarly interest in interprofessional collaboration, addressing health inequities and the care of older adults with substance use disorder through education in skilled nursing facilities. She was awarded the HRSA-funded Geriatric Academic Career Award in 2019, and despite the pandemic, has successfully promoted and taught geriatric principles to interprofessional learners in nursing homes on the care of patients with opioid use disorder. She is the Medical Director of the Nursing Home Program at the Section of Geriatrics, Boston Medical Center and Boston University Chobanian & Avedisian School of Medicine. She is one of the founding members of the Decanter Program at Boston Medical Center, working with an interprofessional team addressing social determinants of health by identifying uninsured or underinsured patients in the hospital with skilled nursing and therapy needs, and transitioning them to post-acute care facilities.

Zhiqiu Ye, PhD

Zhiqiu Ye, PhD, is a delivery system science fellow at the University of Chicago Medicine. Dr. Ye is a clinician health services researcher with extensive training in applied economics focusing on aging-related topics. Her research focuses on improving the quality and equity of care for older adults through improved quality measurement and regulation. She worked as a Prevention Effectiveness Fellow in Health Economics from 2019-2021 within the Division for Heart Disease and Stroke Prevention at the Centers for Disease Control and Prevention (CDC).

Justine Landi, MD

Justine Landi, MD, is an Assistant Professor of Medicine and faculty at the MacLean Center for Clinical Medical Ethics at University of Chicago. Her scholarly interests are focused on care of older adults with Opioid Use Disorder, specifically focused on the clinical and ethical challenges of managing OUD with co-occurring dementia in the outpatient, inpatient, and PALTC settings. She is a medical educator, specifically teaching medical students, residents, and fellows the principles of geriatric and palliative medicine, clinical medical ethics, and serious illness communication.

Stacie Levine, MD

Stacie Levine, MD, is Professor and Chief of Geriatrics and Palliative Medicine at University of Chicago Medicine (UCM) and serves as the regional Medical Director of the Symphony Post Acute Network, a nursing home (NH) chain that owns 29 facilities operating in Illinois, Indiana, Michigan. Her academic interests focus on education and program development to improve care for vulnerable older adults and other patients with complex comorbid illnesses. She is an experienced mentor of physicians and allied health professionals and a national leader in geriatrics and palliative medicine with extensive experience in creation and dissemination of competency-based educational programs. Dr. Levine has extensive experience in NH care and have been conducting research on opioid and substance use disorders in persons transitioning to NHs. She is currently Co-PI of a large-scale, multi-centered project that involves longitudinal training in clinical and teaching skills, program development, leadership engagement, and patient advocacy for physicians, advanced practice practitioners, psychologists, social workers, and chaplains across the United States and internationally. Dr.Levine has served on various national scientific boards and committees. More recently, she is the Director-at-Large of the American Academy of Hospice and Palliative Medicine (AAHPM) Board of Directors, member of the AAHPM Governance Committee, and Chair of the AAHPM Workforce and Leadership Development Strategic Coordinating Committee. Dr.Levine has been the Bucksbaum Institute Faculty Scholar since 2012 and has been awarded Chicago's Top Doctors in 2013, 2018-2022.

  • 1.5 CME
  • 1.5 CMD Clinical
  • 1.5 MOC

Release Date: 03/29/2023   |   Expiration: 03/01/2026

Credit Statements:

Accreditation: Post-Acute and Long-Term Care Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

CME Designation: Post-Acute and Long-Term Care Medical Association designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CMD Credit Hours: This CME activity has been pre-approved by the American Board of Post-Acute and Long-Term Care Medicine (ABPLM) for up to 1.5 clinical hours toward certification or recertification as a Certified Medical Director (CMD) in post-acute and long-term care medicine. Each physician should claim only those hours of credit actually spent on the activity.

The CMD Program is administered by the ABPLM. Each physician should claim only those credit hours that he/she actually spent in the activity. For further information, contact ABPLM at 410-992-3117 or at cmd@paltmed.org.

ABIM Maintenance of Certification (MOC): Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC points and patient safety credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.

Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Financial Disclosure Statement:

The Association requires the disclosure of all speaker/faculty/planner’s relevant financial relationships; presence of off-label use of a device or medication; and discussion of any experimental, new or evolving topic prior to each accredited education activity.

If the learner perceives any bias toward a commercial product or service, advocation of unscientific approaches to diagnosis or therapy, or recommendation, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients please report this to the Association's staff.

The following speaker(s) disclosed relevant financial relationship(s): 

  • Julie Gammack, MD, CMD (Planner & Speaker): Stockholder: Amarin
  • Kenya Rivas Velasquez, MD, CMD, FAAFP (Planner & Speaker): OptumRx: Stockholder
  • All other planners, speakers, and AMDA staff have no relationships with ineligible companies.

All relevant financial relationships have been identified and mitigated.

Components visible upon registration.